WinstonWınston
Back
LifeMD logo

LifeMD

LFMD
26
Medical - Healthcare Information Services · Healthcare
Price
$3.31
+0.03 (+0.91%)
Market Cap
$160.1M
Exchange
NASDAQ
Winston Score
26
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Data not available
Valuation
Data not available

Share count rising — dilution

+67.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 27.0M (2021) → 45.1M (2025)

Winston Score History

The full picture

LifeMD is a telehealth company that connects patients with licensed doctors and then ships prescription medications and health products directly to their homes. Its main services cover weight loss, hair loss, erectile dysfunction, skincare, and mental health — all handled through online visits instead of in-person doctor appointments. The company operates brands like RexMD and Shapiro MD and sells primarily to adult consumers in the United States.

LifeMD makes most of its money through recurring subscription plans where patients pay monthly or quarterly fees for ongoing care and medication refills. It operates almost entirely in the US and generates strong gross margins — around 86% — because it sells branded and compounded medications with relatively low product costs. However, the company is not yet profitable at the operating level, and its biggest risk is regulatory pressure on compounded GLP-1 weight-loss drugs, which have become a major growth driver but face increasing scrutiny from the FDA as branded alternatives become more widely available.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-24.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-149.2% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$7M/ year

Declining (-23% vs prior year)

3.8% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

17.1%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~7 months

$25M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

LifeMD has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
88.8%
Premium pricing power — 88.8% gross margin
Profit after running costs
Operating Margin
-15.1%
Losing money on operations — -15.1%
Return on the money invested
ROCE
-240.1%
Weak — -240.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-16.7%
Shrinking sales (-16.7% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-9.8%
Burning cash (-9.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial